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Summary
Spondylometaphyseal dysplasia (SMD) comprises a het-
erogeneous group of heritable skeletal dysplasias char-
acterized by modifications of the vertebral bodies of the
spine and metaphyses of the tubular bones. The genetic
etiology of SMD is currently unknown; however, the
type X collagen gene (COL10A1) is considered an ex-
cellent candidate, for two reasons: first, Schmid meta-
physeal chondrodysplasia, a condition known to result
from COL10A1 mutations, shows a significant pheno-
typic overlap with SMD; and, second, transgenic mice
carrying deletions in type X collagen show SMD phe-
notypes. Hence, we examined the entire coding region
of COL10A1 by direct sequencing of DNA from five
unrelated patients with SMD and found a heterozygous
missense mutation (Gly595Glu) cosegregating with the
disease phenotype in one SMD family. This initial doc-
umented identification of a mutation in SMD expands
our knowledge concerning the range of the pathological
phenotypes that can be produced by aberrations of type
X collagen (type X collagenopathy).
Introduction
Spondylometaphyseal dysplasia (SMD [MIM 184250,
MIM 184252, MIM 184253, MIM 184255, MIM
313420, and MIM 602271]) is a group of heritable skel-
etal dysplasias characterized by modifications of the ver-
tebral bodies of the spine and metaphyses of the tubular
bones. The clinical hallmark of SMD is short stature
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mainly due to shortening of the trunk and occasionally
associated with micromelia and deformities of extrem-
ities, such as coxa vara and genu varum (Kozlowski et
al. 1967; Maroteaux and Spranger 1991; Taybi and
Lachman 1996). A diagnosis of SMD rests on radiolog-
ical abnormalities, and the diagnostic requisite com-
prises platyspondyly (flattening of the vertebral bodies)
and metaphyseal dysplasia (generalized modifications of
metaphyses of the tubular bones) (fig. 1). SMD is clin-
ically and genetically heterogeneous, and the classifica-
tion of SMD remains tentative. A few subtypes of SMD,
such as the most common (Kozlowski type [Kozlowski
et al. 1967]) and the second most common (corner frac-
ture type), are well-defined distinctive entities (Taybi and
Lachman 1996). However, there are a lot of rare sub-
types and numerous unclassifiable cases still waiting for
rational clarification (Taybi and Lachman 1996).
The genetic etiology of SMD is currently unknown;
however, the type X collagen gene (COL10A1) is con-
sidered an excellent candidate, because type X collagen
is a cartilage-specific short-chain collagen (Schmid and
Linsenmayer 1985) that is expressed specifically in hy-
pertrophic zones of the growth plate (Kirsch and von
der Mark 1991). Derangement of type X collagen could
lead to dysplasias of the spine and metaphyses which
are formed as a result of enchondral ossification. Mu-
tations of type X collagen have been found in patients
with Schmid metaphyseal chondrodysplasia (Schmid
MCD) (Warman et al. 1993; Kuivaniemi et al. 1997),
an autosomal dominant condition characterized by dys-
plasias of metaphyses. Unlike SMD, Schmid MCD al-
most exclusively involves metaphyses of the long bones
but not the spine (Lachman et al. 1988); however, the
metaphyseal alterations of the long bones are very sim-
ilar in both disorders. Furthermore, transgenic mice car-
rying deletions in the triple-helical domain of type X
collagen have shown phenotypes of SMD (Jacenko et al.
1993).
To clarify this issue, we examined the entire coding
region and flanking sequences of COL10A1 in patients
with SMD. We detected in one patient a heterozygous
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Figure 1 Radiographs of a patient (the proband, III-5)with SMD
at the age of 11 years. Left, Lateral radiograph of the lower spine,
showing severe spinal dysplasia. Right, Radiograph of the legs, show-
ing metaphyseal dysplasias with coxa vara.
missense mutation in the C-terminal globular domain of
the gene, which segregated with the disease phenotype
in his family. This is the first documented identification
of a mutation in SMD.
Patients, Material, and Methods
Patients and DNA Samples
Patients were identified and followed up at special
clinics in the Tokyo Metropolitan Kiyose Children’s
Hospital, the Dokkyo University Hospital, and the Na-
tional Rehabilitation Center for Disabled Children. Di-
agnosis of SMD was made on the basis of clinical and
radiographic examinations that showed short-trunked
short stature and generalized dysplasias of the spine and
metaphyses of the long tubular bones.
Five unrelated Japanese patients with SMD were in-
cluded in this study. They were subclassified as follows:
Kozlowski type, two cases; corner fracture type, one
case; Japanese type, one case, and unspecified SMD, one
case. The patient with Japanese-type SMD had a positive
family history compatible with autosomal dominant in-
heritance; the detailed phenotypes of the familymembers
have been reported elsewhere (Hasegawa et al. 1994).
The other four SMD patients were sporadic.
Informed consent was obtained from patients and
members of their families before blood samples were
drawn. Genomic DNAs were extracted by standard
procedures.
PCR and Direct Sequencing
We used sets of primers described elsewhere (Ikegawa
et al. 1997) to amplify the entire coding region of the
COL10A1 gene, with its flanking regions, by PCR. The
PCRs were performed with the Takara exTaq system
(Takara Shuzo) according to the instructions of the man-
ufacturer, in a total volume of 50 ml, with 50–100 ng
of genomic DNA serving as a template. PCR products
were purified by Ultrafree-MC (Millipore) and were se-
quenced directly by the ABI377 automated sequencer
with the Prism Ready Reaction DyeDeoxy Terminator
Cycle Sequencing Kit (ABI).
RFLP Analysis
The region containing nucleotide (NT) 1784 (NTs
1688–1962 [NTs are numbered starting from the initial
base of the initiation codon as 1]) of the COL10A1
gene (Thomas et al. 1991) was amplified by primers 5G
(sense primer: 5′-CAGCAATAGGAACTCCCATACC-
3′) and 3G (antisense primer: 5′-AAGCTGGAGCCA-
CACCTG-3′). The PCR procedure was as follows: initial
denaturation (94C, 2 min) followed by 35 cycles of
denaturation (94C, 30 s), annealing (55C, 30 s), and
extension (72C, 30 s), with a final extension step (72C,
5 min). PCR products were digested for 10–12 h with
10–20 U of BstNI /mg DNA (New England Biolabs) at
60C, then electrophoresed on 3% NuSieve GTG aga-
rose gels (FMC).
Results and Discussion
The entire coding region of the COL10A1 gene with
flanking regions was examined for mutations. In the one
patient with Japanese-type SMD (Hasegawa et al. 1994),
we detected a GrA transversion at NT 1784 (fig. 2A)
in one allele. The mutation occurred in the C-terminal
globular domain of the gene and resulted in the substi-
tution of a glutamic acid residue for a glycine at codon
595 (G595E).
Since G595E resulted in the loss of a BstNI restriction-
enzyme site, we performed PCR-RFLP analysis to ex-
amine the inheritance of the mutated 595E allele and its
link with the disease in the patient’s family. We found
the mutation segregated with the disease phenotype (fig.
2B). The G595E mutation was absent in 50 normal in-
dividuals and other patients with SMD.
G595 of type X collagen is highly conserved. A se-
quence comparison of the C-terminal globular domains
revealed that G595 is identical among chick, bovine,
mouse, and human type X collagens; the residue is also
identical in other short-chain collagen genes, human
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Figure 2 Type X collagen (COL10A1) gene mutation in a Jap-
anese family with SMD. A, Direct sequencing of PCR products dem-
onstrating heterozygosity for G (wild-type allele) and A (mutant allele)
at NT 1784. The G1784rA mutation resulted in the substitution of
a glutamic acid residue for a glycine at codon 595 (G595E).B, Pedigree
and RFLP analysis of the COL10A1 gene in the family. Blackened
symbols on the pedigree represent affected individuals; unblackened
symbols represent unaffected individuals. The G595E mutation abol-
ished a BstNI site, yielding a mutant 210-bp band in heterozygous
patients, in addition to the wild-type 116-bp and 94-bp bands. The
mutation cosegregates with the disorder in this family.
COL8A2 and rabbit Col8a1, and collagen-like mole-
cules, the human C1qA-C complement chains (Brass et
al. 1992). Thus, two lines of evidence lead to the con-
clusion that the G595E mutation causes the SMD phe-
notype in this family. This is the first mutation charac-
terized in SMD.
Previous studies screened for theCOL10A1mutations
in patients with SMD, including the Kozlowski type and
corner fracture type, and found no mutations (Warman
et al. 1993; Wallis et al. 1996). In the present study, we
also failed to identify COL10A1 mutations in four of
five SMD patients. These results suggest that COL10A1
mutations in SMD may not be frequent. Whether other
forms of SMD and SMD-like conditions are caused by
COL10A1 mutations remains to be determined.
Our observation presents in vivo evidence that type
X collagen plays a critical role in the formation of the
human spine as well as the long bones. In addition, our
observation expands the range of pathological pheno-
types that can be produced by aberration of type X col-
lagen (type X collagenopathy). Significant phenotypic
variability due to allelic heterogeneity that is caused by
different mutations in the same gene is not uncommon
in skeletal dysplasias. FGFR3 (fibroblast growth-factor
receptor 3) mutations produce a gradiation of pheno-
types, from very mild hypochondroplasia through in-
termediate achondroplasia to severe thanatophoric dys-
plasia (Bonaventure et al. 1996). Similarly, mutations in
the type II collagen gene cause a wide spectrum of man-
ifestations including spondyloepiphyseal dysplasia con-
genita, hypochondrogenesis, Kniest disease, and Stickler
syndrome (Spranger et al. 1994; Kulvaniemi et al. 1997).
Mutations of COL10A1 appear to lead to a phenotypic
spectrum that includes Schmid MCD and SMD. The full
extent as well as the pathological mechanism of type X
collagenopathies must be clarified by additional studies.
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